CIK 0001429260
- Non-accelerated filer
- Smaller reporting company
Fortress Biotech, Inc.
Sign in to watch- Ticker
- FBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 205157386
- Phone
- +1 781-652-4500
- Business address
- 1111 KANE CONCOURSE, SUITE 301, BAY HARBOR ISLANDS, FL, 33154
- Former names
- Fortress Biotech, Inc., CORONADO BIOSCIENCES INC
Securities
- FBIO Common Stock Nasdaq
- FBIOP 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock Nasdaq
- Open-market buys, last 90 days
- $340,397
- in 2 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$340,397. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2013-05-31 | RITTER DALE SVP & Chief Accounting Officer | Purchase | +1,503 | $3.88 | $6K | 11,503 |
| 2013-05-31 | Lu Lucy Chief Financial Officer | Purchase | +4,979 | $3.88 | $19K | 14,979 |
| 2013-05-31 | Beerman Noah D Executive VP and COO | Purchase | +5,000 | $3.88 | $19K | 15,000 |
| 2013-04-05 | SANDAGE BOBBY W PHD President | Gift | −3,000 | 22,311 | ||
| 2013-02-07 | ROSENWALD LINDSAY A MD Director | Grant or award · Options to purchase Common Stock | +15,000 | 15,000 | ||
| 2013-02-07 | LOBELL J JAY Director | Grant or award · Options to purchase Common Stock | +15,000 | 15,000 | ||
| 2013-02-07 | Harvey Jimmie Director | Grant or award · Options to purchase Common Stock | +15,000 | 15,000 | ||
| 2013-02-07 | BARRETT DAVID JONATHAN Director | Grant or award · Options to purchase Common Stock | +15,000 | 15,000 | ||
| 2013-02-07 | ROGERS MICHAEL W Director | Grant or award · Options to purchase Common Stock | +15,000 | 15,000 | ||
| 2013-01-14 | Weisman Harlan F Chairman and CEO | Purchase | +20,000 | $5.71 | $114K | 20,000 |
| 2013-01-07 | Weisman Harlan F Chairman and CEO | Grant or award · Options to purchase Common Stock | +1,686,590 | 1,686,590 | ||
| 2012-11-30 | SANDAGE BOBBY W PHD President and CEO | Purchase | +3,811 | $4.02 | $15K | 25,311 |
| 2012-11-30 | COOPER GLENN L MD Director | Purchase | +3,811 | $4.02 | $15K | 43,811 |
| 2012-06-22 | ROSENWALD LINDSAY A MD Director | Purchase | +200,000 | $5.00 | $1.0M | 2,659,001 |
| 2012-06-22 | Lu Lucy Chief Financial Officer | Purchase | +10,000 | $5.00 | $50K | 10,000 |
| 2012-06-22 | Hehenberger Karin M. | Purchase | +20,000 | $5.00 | $100K | 20,925 |
| 2012-06-22 | SANDAGE BOBBY W PHD President and CEO | Purchase | +10,000 | $5.00 | $50K | 21,500 |
| 2012-06-22 | Beerman Noah D EVP & COO | Purchase | +5,000 | $5.00 | $25K | 10,000 |
| 2012-06-22 | LOBELL J JAY Director | Purchase | +25,000 | $5.00 | $125K | 321,000 |
| 2012-06-22 | COOPER GLENN L MD Director | Purchase | +10,000 | $5.30 | $53K | 40,000 |
Page 13 of 15 · 297 trades